DPP4 and chronic kidney disease: A series of experimental studies has shown DPP-4 inhibitors to have beneficial effects on renal inflammation/oxidative stress, natriuresis, fibrosis, and apoptosis under diabetic conditions and to exert renoprotective effects in diabetic models as well as non-diabetic CKD models.